282 related items for PubMed ID: 25342092
1. High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone.
Goto M, Miyagawa N, Kikunaga K, Miura M, Hasegawa Y.
Endocr J; 2015; 62(2):145-51. PubMed ID: 25342092
[Abstract] [Full Text] [Related]
2. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
3. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A, RAISE study group investigators.
Lancet; 2012 Apr 28; 379(9826):1613-20. PubMed ID: 22405251
[Abstract] [Full Text] [Related]
4. Hypothalamic-pituitary-adrenal axis recovery following prolonged prednisolone therapy in infants.
Mendoza-Cruz AC, Wargon O, Adams S, Tran H, Verge CF.
J Clin Endocrinol Metab; 2013 Dec 28; 98(12):E1936-40. PubMed ID: 24081733
[Abstract] [Full Text] [Related]
5. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
Kuperman H, Damiani D, Chrousos GP, Dichtchekenian V, Manna TD, Filho VO, Setian N.
J Clin Endocrinol Metab; 2001 Jul 28; 86(7):2993-6. PubMed ID: 11443157
[Abstract] [Full Text] [Related]
6. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.
Schlaghecke R, Kornely E, Santen RT, Ridderskamp P.
N Engl J Med; 1992 Jan 23; 326(4):226-30. PubMed ID: 1309389
[Abstract] [Full Text] [Related]
7. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S, Bertorello N, Masera N, Farinasso L, Barisone E, Rizzari C, Corrias A, Villa A, Riva F, Saracco P, Pastore G.
Pediatr Blood Cancer; 2008 Mar 23; 50(3):537-41. PubMed ID: 17828747
[Abstract] [Full Text] [Related]
8. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
J Clin Endocrinol Metab; 1989 May 23; 68(5):912-6. PubMed ID: 2541160
[Abstract] [Full Text] [Related]
9. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
Dale RC, Saleem MA, Daw S, Dillon MJ.
J Pediatr; 2000 Nov 23; 137(5):723-6. PubMed ID: 11060542
[Abstract] [Full Text] [Related]
10. Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants.
Ng PC, Lam CW, Lee CH, Ma KC, Fok TF, Chan IH, Wong E.
J Clin Endocrinol Metab; 2002 Oct 23; 87(10):4621-8. PubMed ID: 12364445
[Abstract] [Full Text] [Related]
11. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul 23; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
12. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis.
Kirwan JR, Hickey SH, Hällgren R, Mielants H, Björck E, Persson T, Wollheim FA.
Arthritis Rheum; 2006 May 23; 54(5):1415-21. PubMed ID: 16645969
[Abstract] [Full Text] [Related]
13. Bradycardia Associated with Prednisolone in Children with Severe Kawasaki Disease.
Nagakura A, Morikawa Y, Sakakibara H, Miura M.
J Pediatr; 2017 Jun 23; 185():106-111.e1. PubMed ID: 28343657
[Abstract] [Full Text] [Related]
14. Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.
Kimura M, Harazaki M, Fukuoka T, Asakura I, Sakai H, Kamimaki T, Ohkawara I, Akiyama N, Tsurui S, Iwashima S, Shimomura M, Morishita H, Meguro T, Seto S.
Pediatr Int; 2017 Apr 23; 59(4):397-403. PubMed ID: 27743415
[Abstract] [Full Text] [Related]
15. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H.
Rheumatology (Oxford); 2020 Oct 01; 59(10):2764-2773. PubMed ID: 32031663
[Abstract] [Full Text] [Related]
16. Single serum cortisol values at 09:00 h can be indices of adrenocortical function in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone.
Goto M, Miyagawa N, Kikunaga K, Miura M, Hasegawa Y.
Clin Pediatr Endocrinol; 2015 Jul 01; 24(3):69-75. PubMed ID: 26594091
[Abstract] [Full Text] [Related]
17. Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents.
Mahachoklertwattana P, Vilaiyuk S, Hongeng S, Okascharoen C.
J Pediatr; 2004 Jun 01; 144(6):736-40. PubMed ID: 15192618
[Abstract] [Full Text] [Related]
18. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
Arch Dis Child; 2008 Feb 01; 93(2):142-6. PubMed ID: 17962370
[Abstract] [Full Text] [Related]
19. Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy.
Sidoroff M, Kolho KL.
BMC Gastroenterol; 2014 Mar 24; 14():51. PubMed ID: 24661924
[Abstract] [Full Text] [Related]
20. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.
Brigell DF, Fang VS, Rosenfield RL.
J Clin Endocrinol Metab; 1992 May 24; 74(5):1036-9. PubMed ID: 1314844
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
